Clinical trial · Interventional
Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up
NCT00929084CI-TRIAL-00085560completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate in a randomized controlled trail, an innovative cancer communication strategy to help African American breast cancer patients cope with a variety of challenges during and after treatment and to better adhere to recommended treatment guidelines and follow-up care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| The Survivor Stories Tablet | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Survivor Stories Arm
- description
- Women in the Survivor Stories intervention arm will be given the Survivor Stories Tablet to take home for two weeks at three different time points over a two year period.
- interventionNames
- Other: The Survivor Stories Tablet
- type
- OTHER
- label
- Control Arm
- description
- Women in the Control Arm will receive standard care.
- interventionNames
- Other: The Survivor Stories Tablet
Primary outcomes (1)
- measure
- Determine to what extent African American breast cancer survivor stories affect various aspects of QOL, including depressed mood and concern about recurrence, among African American breast cancer patients following primary treatment.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
Show eligibility criteria text
Inclusion Criteria: * African American women * First primary ductal carcinoma in situ (DCIS) or stages I, II, or III invasive breast cancer. Exclusion Criteria: * Prior DCIS or breast cancer diagnosis * Stage IV or metastatic breast cancer * Planned to receive a double mastectomy * non-English speaking, * Having known psychiatric or neurologic disorders * Being cognitively impaired according to weighted error scores on the Orientation-Memory-Concentration Test * Being unwilling or unable to give consent
References
Publications (6)
- RESULTThompson T, Perez M, Kreuter M, Margenthaler J, Colditz G, Jeffe DB. Perceived social support in African American breast cancer patients: Predictors and effects. Soc Sci Med. 2017 Nov;192:134-142. doi: 10.1016/j.socscimed.2017.09.035. Epub 2017 Sep 22. PMID 28965004
- RESULTThompson T, Perez M, Yan Y, Kreuter MW, Margenthaler JA, Colditz GA, Jeffe DB. Randomized controlled trial of a breast cancer Survivor Stories intervention for African American women. Soc Sci Med. 2021 Feb;270:113663. doi: 10.1016/j.socscimed.2020.113663. Epub 2020 Dec 29. PMID 33454539
- RESULTPerez M, Kreuter MW, Yan Y, Thompson T, Sefko J, Golla B, Margenthaler JA, Colditz G, Jeffe DB. Feasibility and Acceptability of an Interactive Cancer-Communication Video Program Using African American Breast Cancer Survivor Stories. J Health Commun. 2020 Jul 2;25(7):566-575. doi: 10.1080/10810730.2020.1821132. Epub 2020 Oct 13. PMID 33048635
- RESULTJarvandi S, Perez M, Margenthaler J, Colditz GA, Kreuter MW, Jeffe DB. Improving Lifestyle Behaviors After Breast Cancer Treatment Among African American Women With and Without Diabetes: Role of Health Care Professionals. Ann Behav Med. 2021 Feb 12;55(1):1-13. doi: 10.1093/abm/kaaa020. PMID 32298407
- RESULTSchootman M, Perez M, Schootman JC, Fu Q, McVay A, Margenthaler J, Colditz GA, Kreuter MW, Jeffe DB. Influence of built environment on quality of life changes in African-American patients with non-metastatic breast cancer. Health Place. 2020 May;63:102333. doi: 10.1016/j.healthplace.2020.102333. Epub 2020 May 11. PMID 32543424
- DERIVEDCho B, Perez M, Jeffe DB, Kreuter MW, Margenthaler JA, Colditz GA, Liu Y. Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer. BMC Cancer. 2022 Aug 1;22(1):837. doi: 10.1186/s12885-022-09946-x. PMID 35915419